A neuroscience R&D company initiated a USD 32 million project to upgrade their drug production plant in Durham, North Carolina, aiming to increase manufacturing capacity for an innovative drug that supports Alzheimer’s disease therapies. The project involved a three-month plant shutdown for renovations and equipment installation to accommodate simultaneous filtration cycles of the new drug. DPR Construction was contracted for the project, which included debottlenecking one of the plant’s purification suites and making additional upstream modifications.